Comparing two nerve block techniques for pain relief after hip surgery
Comparison of Analgesic Effectiveness Between Pericapsular Nerve Group (PENG) Block and Lumbar Erector Spinae Plane Block in Patients Undergoing Total Hip Arthroplasty With Spinal Anesthesia: a Randomized Controlled Trial
This study is testing which of two nerve block techniques helps people recover with less pain and fewer opioids after hip surgery.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 52 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Başakşehir Çam & Sakura City Hospital Government |
| Locations | 1 site (Istanbul, Türki̇ye) |
| Trial ID | NCT06821516 on ClinicalTrials.gov |
What this trial studies
This prospective randomized comparative study evaluates the effectiveness of two nerve block techniques, the Pericapsular Nerve Group (PENG) block and the Lumbar Erector Spinae Plane (L-ESP) block, in managing postoperative pain for patients undergoing total hip arthroplasty under spinal anesthesia. Participants over 18 years old will be monitored for pain scores, opioid consumption, and satisfaction for 24 hours post-surgery. The study aims to determine which nerve block provides superior analgesia, reduces opioid dependence, and enhances recovery outcomes.
Who should consider this trial
Good fit: Ideal candidates are adults over 18 years old who are scheduled for total hip arthroplasty and have an ASA score of I-III.
Not a fit: Patients with ASA scores IV-V, chronic pain conditions, or those unable to cooperate with postoperative follow-up may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to improved pain management strategies for hip surgery patients, reducing opioid use and enhancing recovery.
How similar studies have performed: Previous studies have indicated the effectiveness of peripheral nerve blocks in postoperative pain management, suggesting potential success for this comparative approach.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Voluntary willingness to participate in the study. * Patients who will undergo Total Hip Arthroplasty surgery. * Patients aged over 18 years. * ASA score I-II-III. * Patients who are fully oriented and can cooperate. Exclusion Criteria: * ASA score IV-V. * Patients who refuse to participate in the study. * Patients under 18 years of age. * Presence of active infection in the area to be operated on. * Chronic pain and continuous analgesic use. * Patients with coagulation disorders. * Patients who cannot cooperate with postoperative pain follow-up. * Patients with allergies to local anesthetic agents. * Presence of neuropathy or myopathy in the operated extremity.
Where this trial is running
Istanbul, Türki̇ye
- Basaksehir Çam Ve Sakura City Hospital — Istanbul, Türki̇ye, Turkey (Türkiye) (Recruiting)
Study contacts
- Study coordinator: Muzaffer Gencer
- Email: aberkaysune@gmail.com
- Phone: +905059436459
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.